Serological markers in inflammatory bowel diseases.
This chapter is an overview of the literature on serological markers of inflammatory bowel diseases (IBD), focusing on anti-neutrophil cytoplasm autoantibodies (ANCA) and anti- Saccharomyces cerevisiae mannan antibodies (ASCA). The methodology for ANCA and ASCA testing is first introduced. The value of these markers as diagnostic tools is then discussed. Other chapters are devoted to the potential role of ANCA and ASCA in disease monitoring, disease stratification and as subclinical markers in families. Finally reviewed are other antibodies recently tested in clinical trials such as pancreatic antibodies and antibodies directed against bacterial antigens. The role of these antibodies in the pathophysiology of IBD still needs to be assessed. We also need to identify the ASCA immunogen(s) eliciting the antibody response.
Reumaux
Dominique
D
Département d'Hématologie-Immunologie-Cytogénétique, CH Valenciennes, Lille, France.
Sendid
Boualem
B
Poulain
Daniel
D
Duthilleul
Patrick
P
Dewit
O
O
Colombel
Jean-Frédéric
JF
D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood / Q000276:immunology*; D000908:Antibodies, Fungal / Q000097:blood / Q000276:immunology*; D015415:Biomarkers / Q000097:blood*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000097:blood / Q000175:diagnosis* / Q000276:immunology* / Q000503:physiopathology; D008403:Mass Screening; D012441:Saccharomyces cerevisiae / Q000276:immunology*
D019268:Antibodies, Antineutrophil Cytoplasmic; D000908:Antibodies, Fungal; D015415:Biomarkers